Feline
Update (June 15, 2026): Gabapentin Sedation in Cats — ~40% Ataxia Rate Resolves Within 8 Hours
TL;DR. About 40% of cats receiving oral gabapentin before a veterinary visit show transient ataxia or wobbliness that fully resolves within 8 hours -- a rate and timeline that shapes administration timing and client counseling.
What just dropped
- Van Haaften et al. 2017 (https://avmajournals.avma.org/view/journals/javma/251/10/javma.251.10.1175.xml): approximately 40% of gabapentin-treated cats were wobbly at the time of veterinary examination; all side effects resolved within 8 hours after administration
- Published safety review (https://www.mdpi.com/2306-7381/12/10/938): gabapentin mildly to moderately reduces anxiety in cats with a positive overall behavioral safety profile, with sedation as the most commonly noted side effect
Context
Oral gabapentin is the most commonly used pre-visit anxiolytic in cats, with the pivotal randomized crossover trial (Van Haaften et al. 2017) showing significant reduction in owner-assessed cat stress scores during both transportation and veterinary examination. However, the same trial found approximately 40% of cats were wobbly or ataxic at the examination, consistent with central nervous system sedation. Importantly, all side effects resolved within 8 hours of administration in all cats.
This 8-hour resolution window has direct implications for clinical scheduling. Cats administered gabapentin in the morning for a mid-day appointment should be expected to show residual sedation during the visit -- which is expected and does not require intervention. However, clients should be counseled to keep treated cats indoors and limit access to high surfaces (furniture, stairs) during the effect window. A safety review of gabapentin in feline anxiety management confirmed its overall positive behavioral safety profile, with sedation characteristically mild to moderate and self-resolving.
What this changes in gabapentin for pre-visit feline anxiety (https://www.thevoyage.ai/forvets/knowledge/gabapentin-feline-previsit-anxiety)
The quantified sedation rate (~40%) and the confirmed 8-hour resolution window from Van Haaften 2017 are concrete clinical parameters for client preparation that complement the core efficacy evidence on the evergreen page.
Voyage Clinical Desk
From clinical question to SOAP draft -- cited differentials, live dose calculators, owner handouts. Trained on the veterinary canon (Plumb's, Ettinger, JVIM, ACVIM consensus, 50,000+ indexed references). First answer free, no signup.
Open Voyage Clinical Desk: https://www.thevoyage.ai/forvets/ask?context=update-2026-06-15-gabapentin-cats-sedation-management
References
- Van Haaften KA et al. 2017. Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination. JAVMA 251(10):1175-1181. https://avmajournals.avma.org/view/journals/javma/251/10/javma.251.10.1175.xml
- Gabapentin for feline pre-visit anxiety: efficacy and safety profile review (2025). MDPI Vet Sci 12(10):938. https://www.mdpi.com/2306-7381/12/10/938
Related reads
References
More clinical updates
Update (June 15, 2026): Maropitant Reduces Vomiting in CKD Cats Without Impairing Kidney Function Markers
A prospective study found maropitant significantly reduced vomiting in CKD cats while kidney function parameters stayed stable.
Read →Update (June 15, 2026): Mirtazapine Transdermal (Mirataz) as Appetite Stimulant and Antiemetic in Cats
Mirataz combines a +3.9% vs +0.4% placebo weight gain with documented antiemetic properties, making it a dual-action option in CKD and oncology cats.
Read →Update (June 15, 2026): Long-Term Telmisartan for Hypertension in Cats — Noninferior to Benazepril, Sustained BP Control
Telmisartan is noninferior to benazepril for proteinuria (Sent 2015) and demonstrates sustained blood pressure control in long-term hypertension studies in cats.
Read →Update (June 15, 2026): Capromorelin (Entyce) Field Effectiveness — 244 Dogs, 36-58% Food Intake Increase
Pivotal studies: capromorelin produced 36-58% food intake increases; field effectiveness confirmed in 244 client-owned dogs (177 in effectiveness analysis).
Read →